介入放射学在儿童肝脏肿瘤管理中的作用:第1部分:血管内介入治疗
本文概述介入放射学在儿童肝脏恶性肿瘤诊断与血管内治疗中的作用。儿童原发性肝恶性肿瘤以肝母细胞瘤和肝细胞癌为主,肝母细胞瘤多模式治疗后总生存率接近80%,但部分无法切除或移植;肝细胞癌5年生存率低于30%。经动脉化疗栓塞在成人晚期肝恶性肿瘤中有I级证据支持为标准治疗,在儿童中虽可行但已发表经验主要限于小型回顾性病例系列,缺乏前瞻性试验证据。
要点
- 经动脉化疗栓塞在成人晚期肝恶性肿瘤中有I级证据支持为标准治疗,可延长无病进展、降期、桥接手术或移植并改善总生存。
- 儿童肝母细胞瘤多模式治疗后总生存率接近80%,但部分患儿无法切除或移植。
- 儿童肝细胞癌5年生存率低于30%,治疗挑战显著。
核心结论
- 介入肿瘤学提供经皮和经导管血管内肿瘤治疗,可能为儿童原发性肝肿瘤提供临床获益;经动脉化疗栓塞在成人有I级证据支持为标准治疗,但在儿童中缺乏前瞻性试验证据,已发表经验主要限于小型回顾性病例系列。
研究设计与样本
- 本文为综述,概述介入放射学在儿童肝脏恶性肿瘤诊断与血管内治疗中的作用,未报告系统检索范围与纳入文献数量。
临床应用与阅片要点
- 作者指出,经动脉化疗栓塞在成人晚期肝恶性肿瘤中有I级证据支持为标准治疗,可延长无病进展、降期、桥接手术或移植并改善总生存;在儿童中虽可行,但已发表经验主要限于小型回顾性病例系列,缺乏前瞻性试验证据部分限制了其在儿科人群中的应用。
局限性
- 儿童经动脉化疗栓塞的已发表经验主要限于小型回顾性病例系列。
- 缺乏前瞻性试验证据,部分限制了经动脉化疗栓塞在儿科患者人群中的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Primary liver malignancies are rare in children. Hepatoblastoma and hepatocellular carcinoma (HCC) together represent the overwhelming majority of cases. Overall survival of hepatoblastoma approaches 80% with multimodal treatment approaches that include chemotherapy, surgery and transplantation. However, there remains a subset of children with hepatoblastoma in whom resection or transplantation is not possible. The 5-year survival for children diagnosed with HCC is less than 30% and remains a significant therapeutic challenge. The poor outcomes for children with primary liver tumors motivate investigation of new therapeutic alternatives. Interventional oncology offers a broad scope of percutaneous and transcatheter endovascular cancer therapies that might provide clinical benefits. Minimally invasive approaches are distinct from medical, surgical and radiation oncologic treatments, and in adults these approaches have been established as the fourth pillar of cancer care. Transarterial chemoembolization is a minimally invasive locoregional treatment option performed by interventional radiologists with level-I evidence as standard of care in adults with advanced liver malignancy; transarterial chemoembolization in adults has served to prolong disease-free progression, downstage and bridge patients for surgical and transplant interventions, and improve overall survival. However, while several groups have reported that transarterial chemoembolization is feasible in children, the published experience is limited primarily to small retrospective case series. The lack of prospective trial evidence has in part limited the utilization of transarterial chemoembolization in the pediatric patient population. The purpose of this article is to provide an overview of the role of interventional radiology in the diagnosis and endovascular management of hepatic malignancies in children.
引用
- Lungren MP, Towbin AJ, Roebuck DJ, et al. Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions. Pediatr Radiol. 2018. PMID: 29362840. doi:10.1007/s00247-018-4068-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。